Showing 1 - 20 results of 34 for search 'Miriam Longo', query time: 0.05s Refine Results
  1. 1
    Mediterranean Diet and Sexual Health

    Mediterranean Diet and Sexual Health by Miriam Longo, Paola Caruso, Katherine Esposito

    Published 2020-12-01
    Get full text
    Article
  2. 2
    Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease

    Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease by Marica Meroni, Miriam Longo, Paola Dongiovanni

    Published 2020-08-01
    Get full text
    Article
  3. 3
    Nutrition and Genetics in NAFLD: The Perfect Binomium

    Nutrition and Genetics in NAFLD: The Perfect Binomium by Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni

    Published 2020-04-01
    Get full text
    Article
  4. 4
    Genetics Is of the Essence to Face NAFLD

    Genetics Is of the Essence to Face NAFLD by Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni

    Published 2021-09-01
    Get full text
    Article
  5. 5
    The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH

    The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH by Erika Paolini, Miriam Longo, Alberto Corsini, Paola Dongiovanni

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

    Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni

    Published 2022-03-01
    Get full text
    Article
  7. 7
    Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC

    Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni

    Published 2021-04-01
    Get full text
    Article
  8. 8
    MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD

    MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD by Marica Meroni, Miriam Longo, Anna L. Fracanzani, Paola Dongiovanni

    Published 2020-07-01
    Get full text
    Article
  9. 9
    Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

    Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes by Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Katherine Esposito

    Published 2021-01-01
    Get full text
    Article
  10. 10
    GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off

    GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off by Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Giuseppe Bellastella, Katherine Esposito

    Published 2021-10-01
    Get full text
    Article
  11. 11
    Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC

    Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC by Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani

    Published 2021-10-01
    Get full text
    Article
  12. 12
    miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis

    miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis by Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani

    Published 2018-12-01
    Get full text
    Article
  13. 13
    Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes

    Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes by Maria Ida Maiorino, Giuseppe Bellastella, Miriam Longo, Paola Caruso, Katherine Esposito

    Published 2020-09-01
    Get full text
    Article
  14. 14
    Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia

    Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia by Marica Meroni, Miriam Longo, Miriam Longo, Erika Paolini, Erika Paolini, Giada Tria, Michela Ripolone, Laura Napoli, Maurizio Moggio, Anna Ludovica Fracanzani, Anna Ludovica Fracanzani, Paola Dongiovanni

    Published 2022-09-01
    Get full text
    Article
  15. 15
    When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes

    When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes by Paola Caruso, Maurizio Gicchino, Miriam Longo, Lorenzo Scappaticcio, Ferdinando Campitiello, Katherine Esposito

    Published 2022-01-01
    Get full text
    Article
  16. 16
    SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs

    SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs by Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito

    Published 2021-12-01
    Get full text
    Article
  17. 17
    Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

    Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies by Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito

    Published 2020-07-01
    Get full text
    Article
  18. 18
    Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

    Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy by Miriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, Juris J. Meier, Katherine Esposito, Dario Giugliano

    Published 2019-02-01
    Get full text
    Article
  19. 19
    The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value

    The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value by Erika Paolini, Erika Paolini, Miriam Longo, Miriam Longo, Marica Meroni, Giada Tria, Annalisa Cespiati, Annalisa Cespiati, Rosa Lombardi, Rosa Lombardi, Sara Badiali, Marco Maggioni, Anna Ludovica Fracanzani, Anna Ludovica Fracanzani, Paola Dongiovanni

    Published 2023-03-01
    Get full text
    Article
  20. 20
    The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

    The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs by Dario Giugliano, Miriam Longo, Simona Signoriello, Maria Ida Maiorino, Bruno Solerte, Paolo Chiodini, Katherine Esposito

    Published 2022-03-01
    Get full text
    Article

Search Tools: